1. Prominent US businessperson Stephen Schwarzman will donate $2.5 million over two and a half years to the CiRA Foundation at Kyoto University, headed by Nobel Laureate Yamanaka Shinya, for research on cancer therapy using iPS cell technology.
2. The foundation aims to reduce risks in cancer therapy using iPS cells generated from patient cells and create new genome-edited iPS cell stocks with various functions.
3. The donation will be used to fund the projects initially and potentially start a clinical study as early as fiscal 2028, offering new treatment options for cancer in Japan.
2. The foundation aims to reduce risks in cancer therapy using iPS cells generated from patient cells and create new genome-edited iPS cell stocks with various functions.
3. The donation will be used to fund the projects initially and potentially start a clinical study as early as fiscal 2028, offering new treatment options for cancer in Japan.
Similar Readings (5 items)
Experts okay Japanese team's use of iPS cells for spinal cord injuries
Team: iPS-derived cornea transplant proved safe, effective
iPS-derived heart cell transplant conducted at university in southwest Japan
Researchers announce first iPS cell transplant for cornea disease
Summary: Japanese Nobel Prize winner expresses hope for advances in immunology
Summary
Business magnate Stephen Schwarzman will donate $2.5 million to Kyoto University's CiRA Foundation led by Nobel Laureate Yamanaka Shinya, for research on cancer therapy using iPS cell technology. The foundation aims to minimize risks in cancer treatment with patient-derived iPS cells and develop
Reading History
| Date | Name | Words | Time | WPM |
|---|---|---|---|---|
| 2025/10/16 07:48 | Anonymous | 95 | 39s | 146 |
Statistics
95
Words1
Read CountDetails
ID: 9285e01b-1152-48b1-a45e-b546dfc059d9
Category ID: listed_summary
URL: https://www3.nhk.or.jp/nhkworld/en/news/20251015_18/#summary
Date: Oct. 15, 2025
Notes: 2025-10-15
Created: 2025/10/16 04:10
Updated: 2025/12/08 00:18
Last Read: 2025/10/16 07:48